Organometallics
Article
P2C31H41RhSB9N requires 722], 582 [(M+ − PMe2Ph − 2H),
isotope envelope].
Synthesis of [1,1-(PMe3)2-3-(Py)-closo-1,2-RhSB9H8] (12). A
Schlenk tube was charged with 2 (112.8 mg, 0.1333 mmol). The
rhodathiaborane was dissolved in 10 mL of CH2Cl2, and then three
equivalents of PMe3 (399.9 μL, 0.399 mmol) was added under an argon
atmosphere. The resulting solution was heated at 70 °C in an argon
atmosphere for 12 h. Then, solvent was evaporated, and the resulting
solid crystallized in CH2Cl2/hexane, affording 12. Yield: 56.1 mg,
0.1189 mmol, 89.2%. 31P{1H} NMR (121 MHz; CDCl3; 300 K): δ −9.3
(2P, d, 1JRh−P = 147 Hz). Anal. Calcd for C11H31B9NP2RhS: C, 28.02; H,
6.62; N, 2.97; S, 6.80. Found: C, 27.86; H, 6.59; N, 2.86; S, 6.48.
Synthesis of [1,1-(CO)(PMe2Ph)-3-(Py)-closo-1,2-RhSB9H8]
(16). A 51.02 mg portion of the isomer mixture of 5 (0.0707 mmol)
was loaded in a Schlenk tube and dissolved in 10 mL of CH2Cl2.
A balloon filled with CO(g) was attached to the Schlenk tube; the
system was then cooled in liquid nitrogen and evacuated under vacuum.
The system was exposed to the carbon monoxide atmosphere created
upon opening of the balloon, and the reaction was stirred overnight at
room temperature. The solvent was evaporated under vacuum, and the
red solid studied by NMR. The data demonstrated formation of the
PPh3-ligated closo-rhodathiaborane 14 and the CO-ligated analogue 15
in a 1:4 ratio, which results in a yield of 53% for 16 (nonisolated,
calculated from the NMR data). NMR data of 15: IR(ATR): νmax/cm−1
2507 vs (BH), 1969 vs (CO), 1620 m, 1482 m, 1458 m, 1434 m, 1259 m,
1093 m, 1006 s, 905 s, 799 m, 682 s, 524 m, 488 m. 31P{1H} NMR
Additional NMR data for 5a: 1H{11B} NMR (400 MHz, CD2Cl2):
2
δ +1.53 (3H, doublet, JH−P = 7.5 Hz, PMe2Ph), +1.36 (3H, doublet,
2JH−P = 7.5 Hz, PMe2Ph), −13.02 (1H, q, 1JH−Rh ≈ 2JH−P = 20 Hz, Rh−
H). 31P{1H} NMR (162 MHz; CD2Cl2; 223 K): δ +35.2 (1P, dd,
2
1
1JP−Rh = 128 Hz, JPP = 28 Hz, PPh3), −2.9 (1P, dd, JP−Rh = 105 Hz,
2JP−P = 27 Hz, PMe2Ph).
Additional NMR data for 5b: H{11B} NMR (300 MHz, CDCl3):
1
δ +1.44 (3H, d, 2JH−P = 7.4 Hz, PMe2Ph), +1.01 (3H, d, 2JH−P = 7.7 Hz,
PMe2Ph), −12.78 (1H, q, JH−Rh ≈ JH−P = 22 Hz, Rh−H). 31P{1H}
1
2
1
NMR (162 MHz; CD2Cl2; 223 K): δ +39.2 (1P, dd, JP−Rh = 108 Hz,
2JP−P = 19 Hz, PPh3), −2.1 (1P, dd, JP−Rh = 128 Hz, JP−P = 19 Hz,
1
2
PMe2Ph).
Compound 6. Following the same synthetic steps described for
compounds 4 and 5, 76.1 mg (0.069 mmol) of 2 was treated with two
equivalents of PMe3 (18.5 mL, 0.18 mmol). Yield: yellow product,
0.023 g (0.048 mmol, 54%). Anal. Calcd for C26H39B9NP2RhS: C,
47.33; H, 5.96; N, 2.12; S, 4.86. Found: C, 47.07; H, 5.88; N, 1.45; S,
3.95. IR (ATR): νmax/cm−1 2910 m (BH), 2112 m (RhH). 31P{1H}
1
NMR (161 MHz; CD2Cl2; 223 K): δ 36.9 (dd, JRh−P = 129 Hz,
1
2JP−P = 30 Hz, PPh3), −12.9 (br d, JP−Rh = 103 Hz, PMe3). MS m/z
(MALDI): 409 [M+ − (PPh3 + 1H), isotope envelope;
PC8H33RhSB9N].
1
(202 MHz; CDCl3; 300 K): δ 1.9 (d, JRh−P = 129 Hz, PMe2Ph).
Synthesis of [8,8,8-(H)(PMe2Ph)2-9-(Py)-nido-8,7-RhSB9H9]
(7). 2 (12 mg, 0.014 mmol) was treated with PMe2Ph (7.8 mg, 8
mL, 0.057 mmol) in 10 mL of CH2Cl2. The resulting solution was
stirred under an atmosphere of argon for 2.5 h. Solvent was
evaporated, and the solid subjected to NMR studies in CD2Cl2. The
NMR spectra showed that the product of the reaction contained the
isomers 5a and 5b together with the bis-PMe2Ph-substituted cluster 7
in a 1:1:2 ratio. Isolation of compound 7 was not possible due to its
instability toward dehydrogenation; therefore, the characterization
of 7 was carried out in situ by NMR spectroscopy. 31P{1H} NMR (161
Synthesis of [1,1-(CO)(PMe3)-3-(Py)-closo-1,2-RhSB9H8] (17).
An orange solution of 6 (10 mg, 0.015 mmol) in 2 mL of CD2Cl2
was stirred under an atmosphere of CO(g) at room temperature for
15 min, during which time the initial bright orange solution became
yellow. The final mixture was washed repeatedly with hexane to give
5.9 mg of 17 (0.014 mmol, 92%). IR (ATR): νmax/cm−1 2521 s (BH),
2475 s (BH), 1979 vs (CO), 1620 m, 1480 m, 1457 m, 1434 m, 1156
m, 1091 m, 1006 m, 933 m, 799 m, 681 m. 11B{1H} NMR (160 MHz;
1
CD2Cl2; 298 K): δ 55.0 (1B, s, B-py), 27.4 (1B, d, JB−H = 129 Hz,
BH), 0.7 (1B, br, BH), −1.8 (1B, d, 1JB−H = 120 Hz, BH), −14.1 (1B,
1
MHz; CD21Cl2; 298 K): δ 3.2 (d, JRh−P = 77 Hz, PB trans to B(9)),
br, BH), −25.8 (1B, br, BH), −32.3 (1B, d, 1JB−H = 149 Hz, BH), −33.8
2
−1.8 (dd, JRh−P = 124 Hz, JP−P = 24 Hz, PA trans to B(3)−B(4)
1
1
(1B, d, JB−H = 146 Hz, BH). H NMR (300 MHz; CD2Cl2; 300 K):
δ 9.41 (2H, d, J = 5.6 Hz, Py), 8.26 (1H, m, Py), 7.82 (2H, m, Py), 4.40
(1H, s, BH), 2.51 (1H, s, BH), 2.17 (1H, s, BH), 1.83 (1H, s, BH), +1.35
(3H, d, 2JP−H = 10.3 Hz, PMe3), 0.38 (1H, s, BH), 0.32 (1H, s, BH), 0.05
(1H, s, BH), 0.02 (1H, s, BH). 31P{1H} NMR (202 MHz; CD2Cl2;
300 K): δ −6.1 (d, 1JRh−P = 137 Hz, PMe3); m/z (MALDI−) 421 (M − 4H;
isotope envelop; PC9H22ORhSB9N requires 425).
edge).
Synthesis of [1,1-(PPh3)(PMe2Ph)-3-(Py)-closo-1,2-RhSB9H8]
(9). A 5.9 mg (0.0082 mmol) amount of a mixture of isomers 5a and
5b was dissolved in CD2Cl2 in an NMR tube and heated at 70 °C for
3 h. Solvent was reduced in volume, and hexane added to form a
yellow precipitate, which was separated by decantation, washed with
hexane, and dried under vacuum. The resulting red product was
characterized as 9 (4.2 mg, 0.059 mol, 72%). 31P{1H} NMR (161
MHz; CDCl3; 223 K): δ 50.7 (dd, 1JRhP = 155 Hz, 2JPP = 30 Hz, PPh3),
Reactions of 9−12, 16, and 17 with H2(g). In a typical reaction,
around 10 mg (0.016 mmol) of the closo-rhodathiaboranes was placed
in a screw-capped NMR tube and dissolved in 0.6 mL of CD2Cl2. The
NMR tube was cooled in liquid nitrogen, evacuated, and then filled
with H2. The samples were monitored at different intervals overnight
by 1H NMR spectroscopy, without evidence of changes in the spectra.
Reactions of 4−6 with C2H4. In a Schlenk tube, around 10 mg of
the hydridorhodathiaboranes 4−6 was dissolved in CH2Cl2 (∼8 mL).
A balloon filled with C2H4 was attached to the Schlenk tube; the
system was then cooled in liquid nitrogen and evacuated under
vacuum. The hydrorhodathiaborane solutions were exposed to the
ethylene atmosphere created upon the opening of the balloon, and the
reaction was stirred overnight at room temperature. In the case of
compound 4, the NMR data demonstrated that there was no reaction
with the olefin. In the case of 6, however, there was formation of the
closo-derivative 10. In the same conditions, a mixture of the isomers 5a
and 5b leads to the formation of the bis-PMe2Ph derivative 11.
Compound 6 with Ethylene. Alternatively, the reaction with
compound 6 (5.5 mg, 0.0083 mmol, in 0.4 mL of CD2Cl2) was carried
out in a screw-capped NMR tube, which was exposed to 1.5 bar of
1
2
−6.2 (dd, JRhP = 138 Hz, JPP = 32 Hz, PMe2Ph).
Synthesis of [1,1-(PPh3)(PMe3)-3-(Py)-closo-1,2-RhSB9H8]
(10). A 10 mg (0.021 mmol) sample of 6, placed in an Schlenk
tube, was dissolved in CH2Cl2 and heated to reflux temperature under
an atmosphere of argon for 3 h. Solvent was reduced in volume, and
hexane added to form a yellow precipitate, which was separated by
decantation, washed with hexane, and dried under vacuum. The
resulting yellow product was characterized as 10 (6.9 mg, 0.015 mmol,
69%). 31P{1H} NMR (161 MHz; CDCl3; 300 K) ordered as δP [DFT-
1
2
calcd δP]: 49.2 [67.7] (dd, JRh−P = 157 Hz, JP−P = 29 Hz, PPh3),
1
−15.4 [−3.2] (1P, dd, JRh−P = 146 Hz, PMe3). Anal. Calcd for
C26H37B9NP2RhS: C, 47.47; H, 5.67; N, 2.13; S, 4.87. Found: C,
47.07; H, 5.88; N, 2.39; S, 3.77.
Synthesis of [1,1-(PMe2Ph)2-3-(Py)-closo-1,2-RhSB9H8] (11). A
Schlenk tube was charged with the mixture of isomers 5 (10.1 mg,
0.012 mmoL). The mixture of hydridorhodathiaboranes was dissolved
in 10 mL of CH2Cl2, and then PMe2Ph (2.5 μL, 0.024 mmol) was
added under an argon atmosphere. The resulting solution was heated
at reflux in an argon atmosphere for 12 h. Solvent was evaporated,
and the red residue crystallized in CH2Cl2/hexane to give 6.0 mg
of compound 11 (0.010 mmol, 84%). 31P{1H} NMR (161 MHz;
1
ethylene. After 3 days, the H NMR spectrum at room temperature
exhibits two broad multiplets at +2.27 and +2.05 ppm, which
correspond to the previously reported ethylene-ligated rhodathiabo-
rane, 13. In addition, there are two broad multiplets of higher intensity
at +2.38 and +2.16 ppm, which can be assigned to the rhodium-bound
ethylene ligand of the PMe3-ligated analogue [1,1-(PMe3)(η2-C2H4)-
3-(Py)-closo-1,2-RhSB9H8] (15). At lower temperatures, the two
1
CD2Cl3; 300 K): δ 2.9 (d, JRh−P = 140 Hz). Anal. Calcd for
C21H35B9NP2RhS: C, 42.34; H, 5.92; N, 2.35; S, 5.38. Found: C,
41.88; H, 5.87; N, 2.18; S, 4.70. MS m/z (MALDI): 596 (M+, isotope
envelope; C21H35B9NP2RhS requires 596).
2994
dx.doi.org/10.1021/om2009205 | Organometallics 2012, 31, 2986−2995